Deere & Company’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Deere & Company’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-92,554	Closed	-$1.52M	–	1140
2016 Q2	$1.52M	Sell	92,554 -3,639	-4%	-$58.9K	0.08%	225
2016 Q1	$1.59M	Buy	96,193 +9,775	+11%	+$171K	0.08%	282
2015 Q4	$1.87M	Buy	+86,418	New	+$1.68M	0.11%	195
2015 Q2	–	Sell	-32,721	Closed	-$850K	–	1153
2015 Q1	$850K	Buy	32,721 +17,613	+117%	+$323K	0.05%	440
2014 Q4	$195K	Buy	+15,108	New	+$189K	0.01%	897
2014 Q1	–	Sell	-111,386	Closed	-$849K	–	1102
2013 Q4	$849K	Buy	+111,386	New	+$601K	0.04%	468

Other funds holding HZNP

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Deere & Company's HZNP Position: Q3 2016 in Review

Deere & Company sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2016, closing a stake of 92,554 shares — an estimated $1.52M sold.

Deere & Company first reported a position in HZNP in Q4 2013 and held it in 6 quarters. The position peaked at $1.87M in Q4 2015. 233 funds tracked by Wall St. Rank hold HZNP as of Q3 2016.

Deere & Company reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2016 after selling out during the quarter.
Deere & Company sold 92,554 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2016, an estimated $1.52M.
Deere & Company first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2013 and held it in 6 quarters.
Deere & Company's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.87M in Q4 2015.
233 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2016.

Based on Deere & Company's 13F filing for Q3 2016, filed 14 Nov 2016.